Keeping Up to Date on COVID-19 Vaccines

February 14, 2024

Back
Featured image for “Keeping Up to Date on COVID-19 Vaccines”

As we enter 2023, COVID-19 remains an ever-present health concern. However, great progress has been made, thanks largely to the development and distribution of safe and effective COVID-19 vaccines. Getting fully vaccinated and receiving booster doses when eligible remains our strongest defense against the SARS-CoV-2 virus behind this pandemic.

In particular, new bivalent booster shots designed to provide broader protection against circulating Omicron variants promise better, longer-lasting immunity against both infection and severe disease outcomes. As such, health authorities like the CDC continue to recommend eligible individuals stay up-to-date by getting these updated COVID boosters.

Below we’ll discuss key details around these bivalent vaccines, examine updated booster recommendations for 2023, overview proper dosage schedules, highlight where to conveniently access shots in your area, summarize recent vaccine news and breakthroughs, dismantle continuing misinformation, and answer some frequently asked questions surrounding COVID immunization. Let’s get started!

Understanding Bivalent COVID-19 Vaccines

The original COVID-19 vaccines target the ancestral SARS-CoV-2 strain that emerged in 2019. However, the virus has mutated significantly since then, spawning major variants like Alpha, Beta, Delta, and most impactfully, Omicron.

To counter, Pfizer-BioNTech and Moderna have developed updated bivalent mRNA vaccines that contain components targeting both the original ancestral strain alongside Omicron subvariants. As such, they elicit an immune response against a broader range of viral targets to confer better protection.

The FDA authorized these new bivalent formulations as booster doses for ages 6 months and up in September 2022. Early data indicates they boost antibody levels against Omicron sublineages compared to ancestral boosters alone.

So while the original vaccines still guard strongly against severe disease, these next-gen boosters should blunt infections more effectively and provide more durable protection over time. Especially as Omicron and its offspring remain dominant worldwide.

Booster Recommendations for 2023

Given the current prominence of Omicron spin-offs like BQ.1 and XBB, health bodies like the CDC universally advise all ages 6 months and older get an updated bivalent booster this fall/winter.

Even those already boosted with the original (monovalent) vaccine are urged to receive a bivalent shot as their next booster for enhanced, lingering immunity. Ideally timed before an expected winter infection surge as with previous seasons.

Some key notes regarding eligibility per CDC advice:

  • Initial vaccination: Everyone 6 months+ should complete an original primary vaccination series if unvaccinated currently
  • First booster: Those 5+ years out from completing an initial series should receive their first booster dose if they haven’t already
  • Second/bivalent booster: Everyone 5+ who completed an initial series and are at least 2 months out from their last booster shot should get an Omicron-adapted bivalent booster

While some risk groups like seniors and immunocompromised individuals may qualify for additional boosters (5th dose) later on, right now the priority is getting boosted with the updated bivalent vaccine entering 2023.

COVID-19 Vaccine Schedules

To ensure sufficient, enduring immunity against COVID-19, complete and properly-timed vaccination is critical. Below is an overview of common dosage schedules per vaccine manufacturer:

Pfizer (Comirnaty)

  • Ages 5+ years
    • Primary series: 2 doses, 21 days apart
    • First booster: At least 5 months after second primary dose
    • Bivalent booster: At least 2 months after previous booster
  • Ages 6 months – 4 years
    • Primary series: 3 doses – initial 2 doses 21 days apart, 3rd dose at least 8 weeks after second dose
    • Bivalent booster: At least 2 months after completing primary series

Moderna (Spikevax)

  • Ages 6+ months
    • Primary series: 2 doses, 28 days apart
    • First booster: At least 5 months after second primary dose
    • Bivalent booster: At least 2 months after previous booster

As shown, both mRNA schedules feature a primary two-dose series spaced 3-4 weeks apart, an optional first booster 5 months later, then an Omicron-adapted bivalent booster 2 months after that last dose. Those ages 6 months-4 years receive a 3-dose primary.

Novavax’s protein vaccine also offers a primary 2-dose regimen 3-8 weeks apart with a first booster at least 6 months later. Only ages 12+ currently though.

So while schedules vary slightly between shot types and age groups, the overall cadence of an initial series followed by boosters every 5-6+ months provides a sound immunization foundation over time against the SARS-CoV-2 virus.

Accessing COVID-19 Vaccines

Fortunately, tracking down COVID vaccines in your area is relatively simple these days courtesy of improved production and distribution. Plus prioritization of shipment channels to maintain availability despite residual demand.

Some convenient options to consider:

  • Local pharmacies – Major chains like CVS, Walgreens, Rite Aid, Costco, Albertsons, etc. widely offer COVID shots. Often supporting online scheduling.
  • Primary care clinics & pediatricians – Many general medicine and family/kids doctors provide doses for existing patients.
  • Local health departments – County/municipal public health agencies host regular vaccination drives and clinics.
  • Hospitals & specialty clinics – Larger multi-specialty outpatient clinics, children’s hospitals, etc. tend to accommodate COVID immunization alongside other services.
  • Travel clinics – Private clinics specializing in travel or occupational prophylaxis often stock COVID vaccines also.
  • Vaccines.gov – Federal vaccine locator consolidating availability across major providers and local listing channels.

Using such resources, getting adequately protected through repeat COVID boosters is quite straightforward today, with no out-of-pocket costs in the USA. Now it’s just a matter of actually doing so!

Latest Headlines Concerning COVID-19 Vaccines

Development and mass distribution of the COVID vaccines certainly stands among medicine’s crowning achievements in combatting this outbreak. Nonetheless, research and news remains active in optimizing formulations against emergent viral mutations.

Some recent notable headlines include:

  • Variant-adapted bivalent boosters utilizing mRNA technology should adapt quicker to counter newer viral offspring vs previous inoculations
  • Omicron-tailored bivalent shots display substantially higher antibody levels and activity vs old boosters in trials
  • One bivalent booster shot confers greater T-cell immunity against Omicron subvariants than an initial 3-dose vaccine series
  • Following a primary series, bivalent boosters provide the best protection from symptomatic infection and severe disease
  • Updated Omicron boosters expected to blunt COVID hospitalization rates significantly in vulnerable senior groups

Such developments continue the vaccine’s vital role in mitigating harm from the mutable SARS-CoV-2 threat.

Debunking COVID-19 Vaccine Falsehoods

While lifesaving and overwhelmingly safe, COVID vaccines still attract various deceptive claims questioning their legitimacy and promotion:

Myth: Vaccines don’t stop infection or transmission

Truth: No vaccine prevents all breakthrough cases. But data clearly shows the COVID shots substantially reduce susceptibility to contracting SARS-CoV2 strains along with passing them to others. Particularly via asymptomatic transmission. Plus they lift once infected people’s protection against onward spread. So from both angles they definitively curb viral infectiousness.

Myth: Vaccines have killed thousands

Truth: Over 640+ million fully vaccinated people just in the USA alone, with little attributable risk found. Meanwhile, rigorous analysis verifies the shots slash COVID mortality rates 10X over unprotected groups. While very rare serious side effects like heart inflammation can occasionally result, rates of vaccine-induced death or disability prove vanishingly small. Their life-saving benefits significantly outweigh potential harms.

Myth: Vaccines alter DNA

Truth: The mRNA material in COVID shots break down quickly after entering cells to spur antigen development, without interact with genomic DNA at all. So they cannot genetically reprogram recipients. Traditional definitions of “genetic modification” don’t scientifically apply here whatsoever as the vaccines don’t change DNA sequences in any way.

So although shrill vaccine objections will likely always exist to some degree, maintaining public conviction requires circulating facts, not amplifying fiction.

COVID-19 Vaccine FAQs

Despite mass inoculation efforts well underway, you probably still have lingering questions concerning getting optimally vaccinated against the novel coronavirus. Below we tackle some frequent ones:

How effective are the updated bivalent boosters expected to be?

Early estimates suggest Omicron-adapted bivalent formulations could re-strengthen vaccine efficacy against symptomatic infection into the 50-80% range for several months post-injection before gradually declining. Still highly useful for both personal and community protection against transmission.

Is it safe getting a COVID shot alongside my annual flu vaccine?

Yes, joint administration poses no safety issues or impairment to either vaccine’s intended immune response. Recent CDC analysis even suggests receiving both together slightly boosts antibody development vs getting them separately. So concurrent vaccination represents an efficient strategy.

If I recently had a COVID infection, should I still get a booster?

Natural immunity from prior infection makes for a poor shield against reinfection from antigenically distinct strains. So while the very freshly infected may temporarily delay boosters, getting an Omicron shot 2-6 months afterwards substantially reinforces immune defenses against related subvariants going forward.

How do side effects compare between original and updated booster vaccines?

Overall reactions appear similar. Most commonly transient injection site soreness and systemic malaise, fatigue, muscle aches, feverishness, etc. resolving within several days. Any distinctions emerge non-clinically significant so far. Just take normal precautions for post-vaccination recovery needs.

With bivalent formulations now available, should I opt out of mandated original booster requirements still in effect?

Likely no exemptions exist currently if old boosters specified by past public health statutes or organizational policies. But bivalent boosters will probably formally replace legacy recommendations moving forward. So upcoming vaccine cycles should feature the new Omicron agents instead.

In Conclusion…

Despite recent downtrends in pandemic activity, the ultra-transmissible Omicron variant and its offspring continue plaguing communities worldwide. Our best means for managing spread remains getting up to date on COVID-19 vaccination utilizing new bivalent booster doses that confer better efficacy against these strains.

Fortunately, such shots now rollout en masse, with convenient accessibility through local pharmacies, clinics, health departments, vaccine portals, etc. Those 5+ years old should review schedules and eligibility to receive their indicated primary shot seriesfirst original booster, and critically – an Omicron-adapted bivalent booster this fall/winter without delay.

Keeping boosters current presents our greatest opportunity for enjoying long-term vaccine effectiveness over emerging viral mutations. Ultimately rewarding individuals and public health interests alike with safer, stabler lives through this outbreak’s remainder.

So don’t hesitate to take advantage of medical science’s latest breakthroughs – make time and prepare logistics for getting the COVID shots you need today!

Key Takeaways

  • New bivalent mRNA boosters with Omicron vaccine components enhance protection vs variant sublineages
  • All ages 5+ years urged to get updated bivalent booster 2+ months after previous booster
  • Multiple options exist for conveniently accessing COVID-19 vaccines
  • Research confirms variant-adapted boosters significantly lift antibody levels against Omicron
  • Continued vaccine falsehoods around inefficacy, risk rates, mechanisms, etc. deflate under scientific scrutiny
  • Forthcoming bivalent boosters could restore vaccine efficacy vs symptomatic infection to 50-80% initially
Rate this post

Related articles



Image
Image

MIRARI®
Cold Plasma System

The world's first handheld cold plasma device

Learn More


Made in USA

Image